Novel lipid mediator regulators of endothelial cell proliferation and migration: Aspirin-triggered-15R-lipoxin A4 and lipoxin A4

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 385-392

  Fierro, Iolanda M ^a,b   Kutok, Jeffery L ^c   Serhan, Charles N ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Center for Experimental Therapeutics and Reperfusion Injury   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPI 16 (4 FLUORO)PHENOXYLIPOXIN A4; ANGIOGENESIS INHIBITOR; LEUKOTRIENE D4; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; DNA FRAGMENTATION; EICOSANOIDS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; IMMUNOHISTOCHEMISTRY; LEUKOTRIENE A4; LIPID METABOLISM; LIPOXINS; LYMPHOKINES; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036156691     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.385     Document Type: Article

References (34)

1. Angiogenesis
2. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
3. 4 receptor
4. 4 ELISA
5. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation
6. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions
7. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo
8. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation
9. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions
10. The role of αv integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
11. Angiogenesis in cancer, vascular, rheumatoid and other disease
12. Angiogenesis
13. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
14. 4 analogs
15. 4 and regulation of vascular and inflammatory responses
16. 4 inhibit tumor necrosis factor 1α-initiated neutrophil responses and trafficking: Regulators of a cytokine-chemokine axis
17. Cyclooxygenase gene expression in inflammation and angiogenesis
18. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP
19. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
20. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene
21. Aspirin as prophylaxis against colorectal cancer
22. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function
23. COX-2 inhibitors: A new class of antiangiogenic agents
24. 4 in human renal mesangial cells: Differential activation of MAP kinases through distinct receptors
25. Migration ofleukocytes across endothelium and beyond: Molecules involved in the transmigration and fate of monocytes
26. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis
27. Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase
28. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity?
29. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases
30. The role of NF-κB in the angiogenic response of coronary microvessel endothelial cells
31. 4 stable analogs are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors
32. Aspirin and other anti-inflammatory drugs
33. Angiogenesis and neoplastic progression in vitro